Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1537561/000141057821000550/arth-20210930x10k.htm
July 2022
March 2022
January 2022
December 2021
October 2021
October 2021
September 2021
August 2021
May 2021
April 2021
Document And Entity Information - USD ($) | 12 Months Ended | ||
---|---|---|---|
Sep. 30, 2021 | Dec. 16, 2021 | Mar. 31, 2021 | |
Document And Entity Information | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Period End Date | Sep. 30, 2021 | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
Entity File Number | 000-54986 | ||
Entity Incorporation, State or Country Code | NV | ||
Entity Registrant Name | Arch Therapeutics, Inc. | ||
Entity Tax Identification Number | 46-0524102 | ||
Entity Address, Address Line One | 235 Walnut Street | ||
Entity Address, Address Line Two | Suite 6 | ||
Entity Address, City or Town | Framingham | ||
Entity Address, Country | MA | ||
Entity Address, Postal Zip Code | 01702 | ||
City Area Code | 617 | ||
Local Phone Number | 431-2313 | ||
Title of 12(g) Security | Common Stock, par value $0.001 per share | ||
Entity Central Index Key | 0001537561 | ||
Current Fiscal Year End Date | --09-30 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Public Float | $ 32,000,000 | ||
Trading Symbol | ARTH | ||
Entity Shell Company | false | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Common Stock, Shares Outstanding | 237,169,770 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1537561/000141057821000550/arth-20210930x10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Arch Therapeutics, Inc..
Arch Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Arch Therapeutics, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ARTH
CIK: 1537561
Form Type: 10-K Annual Report
Accession Number: 0001410578-21-000550
Submitted to the SEC: Fri Dec 17 2021 4:16:16 PM EST
Accepted by the SEC: Fri Dec 17 2021
Period: Thursday, September 30, 2021
Industry: Surgical And Medical Instruments And Apparatus